Lung Cancer Screening Intervention Trial
Key Findings
Lung cancer is the deadliest cancer in the US, but early detection through screening improves outcomes. A nonrandomized controlled trial assessed a multifaceted intervention’s impact on identifying and completing recommended lung cancer screening (LCS) services.
Study Details
The trial involved patients aged 55 to 80 years with a history of smoking. The intervention was conducted at primary care and pulmonary clinics in Salt Lake City, Utah, using an electronic health record system.
Interventions and Outcomes
Period 1 interventions for clinicians included reminders and decision-making tools, leading to increased monthly rates of LCS care gap closure. Period 2 added patient-facing reminders, resulting in immediate increases in care gap closure rates. The overall care gap closure rate rose from 15.9% to 46.9% by the end of period 2.
Conclusion
The multifaceted intervention showed improvement in LCS care gap closure, indicating the potential for enhancing lung cancer screening practices.
Practical Solutions and Value
Clinics can benefit from AI-driven platforms like DocSym, which consolidate standards, protocols, and research for easy access. Streamlining operations and expanding services digitally through mobile apps can improve patient care and outcomes.
